These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 11162378)
1. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378 [TBL] [Abstract][Full Text] [Related]
2. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of beta-hematin. Baelmans R; Deharo E; Muñoz V; Sauvain M; Ginsburg H Exp Parasitol; 2000 Dec; 96(4):243-8. PubMed ID: 11162377 [TBL] [Abstract][Full Text] [Related]
3. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs]. Xue J; Jiang B; Liu CS; Sun J; Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850 [TBL] [Abstract][Full Text] [Related]
4. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. Ncokazi KK; Egan TJ Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752 [TBL] [Abstract][Full Text] [Related]
6. Quinoline antimalarials decrease the rate of beta-hematin formation. Egan TJ; Ncokazi KK J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260 [TBL] [Abstract][Full Text] [Related]
7. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328 [TBL] [Abstract][Full Text] [Related]
8. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779 [TBL] [Abstract][Full Text] [Related]
9. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin. Sonnet P; Mullié C Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029 [TBL] [Abstract][Full Text] [Related]
10. Inhibition assay of beta-hematin formation initiated by lecithin for screening new antimalarial drugs. Trang DT; Huy NT; Uyen DT; Sasai M; Shiono T; Harada S; Kamei K Anal Biochem; 2006 Feb; 349(2):292-6. PubMed ID: 16376288 [TBL] [Abstract][Full Text] [Related]
11. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites. Monti D; Vodopivec B; Basilico N; Olliaro P; Taramelli D Biochemistry; 1999 Jul; 38(28):8858-63. PubMed ID: 10413458 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives. Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883 [TBL] [Abstract][Full Text] [Related]
13. Interactions of quinoline antimalarials with hematin in solution. Egan TJ J Inorg Biochem; 2006 May; 100(5-6):916-26. PubMed ID: 16384600 [TBL] [Abstract][Full Text] [Related]
14. Carbon isosteres of the 4-aminopyridine substructure of chloroquine: effects on pK(a), hematin binding, inhibition of hemozoin formation, and parasite growth. Cheruku SR; Maiti S; Dorn A; Scorneaux B; Bhattacharjee AK; Ellis WY; Vennerstrom JL J Med Chem; 2003 Jul; 46(14):3166-9. PubMed ID: 12825955 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Solomon VR; Puri SK; Srivastava K; Katti SB Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868 [TBL] [Abstract][Full Text] [Related]